MolecularMD Capabilities Overview

View PDF

Successful Codevelopment of a Diagnostic, Used for the Detection of the Drug’s Clinical Trial Primary End Point

View PDF

Clinical Trial Strategy and Contingency Planning Rescue Drug Program from Lead Indication Failure

View PDF

MolecularMD Successfully Delivers on a Compressed 16-month CDx Assay Design and PMA Submission in Support of Client’s Pivotal Phase II NDA Filing

View PDF